NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 6.74% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 6.71% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 5.45% |
| QURE | Uniqure NV | Healthcare | Biotechnology | 5.41% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 5.13% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.48% |
| IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | 4.46% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 4.12% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.10% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| DVA | DaVita HealthCare Partners Inc | Healthcare | Medical Care Facilities | 3.86% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.79% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.77% |
| NKTR | Nektar Therapeutics | Healthcare | Biotechnology | 3.71% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.65% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.52% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.46% |
| MASS | 908 Devices Inc | Healthcare | Medical Devices | 3.44% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.42% |
| CCCC | C4 Therapeutics Inc | Healthcare | Biotechnology | 3.40% |